Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03714282 · ClinicalTrials.gov registry record · NA

Noninvasive Spinal Stimulation in Stroke

A NA study, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
NA
Development phase
8
Enrollment target

NCT03714282: Completed NA study, sponsored by Shirley Ryan AbilityLab.

NCT03714282 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03714282, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

This is a randomized control trial that will evaluate the effectiveness of transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals with hemiplegia due to stroke.

Primary Outcome

Participants will ambulate along Gait Rite electronic walkway to evaluate baseline gait pattern at both their self-selected and safe fast gait speed. The GAITRite electronic walkway for the study shall be a minimum of 14 feet long. The GAITRite data capture was chosen as measurement of the patient's overall gait quality. The gait symmetry index of spatio-temporal parameters will be calculated as (100%×(1-\|1-Nonparetic/(Paretic side)\|), which always results in a maximum value of 100%, irrespect

Interventions

  • DEVICE Noninvasive spinal stimulation with gait training
  • DEVICE Conventional gait training

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2018-10-18
Est. Completion 2020-05-14
Phase NA
Shirley Ryan AbilityLab

138 total trials

What the finished NCT03714282 record still lists

NCT03714282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Noninvasive spinal stimulation with gait training is the first listed.

NCT03714282 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03714282 about?

NCT03714282 is a clinical study titled "Noninvasive Spinal Stimulation in Stroke". This is a randomized control trial that will evaluate the effectiveness of transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals with hemiplegia due to stroke.

What is the current status of trial NCT03714282?

This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2018-10-18. Estimated completion is 2020-05-14.

What interventions are being tested in trial NCT03714282?

The interventions under investigation include: Noninvasive spinal stimulation with gait training (DEVICE), Conventional gait training (DEVICE).

Who is sponsoring clinical trial NCT03714282?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03714282's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03714282, the US trial registry maintained by the National Library of Medicine. NCT03714282 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.